Vaxcyte, Inc. PCVX Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCash.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s restricted cash?
- Vaxcyte, Inc. (PCVX) reported restricted cash of $1.47M in Q1 2026.
- How has Vaxcyte, Inc.'s restricted cash changed year-over-year?
- Vaxcyte, Inc.'s restricted cash increased by 11.1% year-over-year, from $1.32M to $1.47M.
- What is the long-term trend for Vaxcyte, Inc.'s restricted cash?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s restricted cash has grown at a 13.9% compound annual growth rate (CAGR), from $871K to $1.47M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.